000 | 01963ngm a2200445 a 4500 | ||
---|---|---|---|
001 | HST9_01_1_3 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 160919s2007 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a1077 _bHenry Stewart Talks |
035 | _a(UkLoHST)676 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aSmith, Dennis A., _u(Pfizer, UK) _4spk |
|
245 | 1 | 0 |
_aIntroduction to drug metabolism enzymes _h[electronic resource] / _cDennis A. Smith. |
260 |
_aLondon : _bHenry Stewart Talks, _c2007. |
||
300 |
_a1 online resource (1 streaming video file (47 min.) : _bcolor, sound). |
||
490 | 1 |
_aDrug metabolizing enzymes : fundamentals, study methods, recent advances and clinical significance, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: Metabolism of lipophilic molecules -- Phase I and Phase II enzymes -- Location -- Mechanism -- Typical substrates -- Genetic variation -- Species variation -- Inhibition and drug interactions -- Drug design. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 | _aDrug interactions. | |
650 | 0 |
_aDrugs _xDesign. |
|
650 | 0 |
_aDrugs _xMetabolism. |
|
650 | 0 | _aEnzymes. | |
650 | 2 | _aBiochemical Processes. | |
650 | 2 | _aDrug Design. | |
650 | 2 | _aDrug Interactions. | |
650 | 2 |
_aEnzymes and Coenzymes _xchemistry. |
|
650 | 2 |
_aEnzymes and Coenzymes _xmetabolism. |
|
650 | 2 |
_aEnzymes and Coenzymes _xpharmacology. |
|
650 | 2 | _aGenetic Variation. | |
650 | 2 |
_aPharmaceutical Preparations _xmetabolism. |
|
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pDrug metabolizing enzymes : fundamentals, study methods, recent advances and clinical significance. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/676/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/16/ _3Series |
999 |
_c76629 _d76629 |